Evidence map›Paper›PMID 29174593›Full record

ArticleBiological psychiatry2018

Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes.

Peter McColgan, Sarah Gregory, Kiran K Seunarine, Adeel Razi, Marina Papoutsi, Eileanoir Johnson, Alexandra Durr, Raymund A C Roos, Blair R Leavitt, Peter Holmans and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Biological psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. The neocortical infrastructure for language involves region-specific patterns of laminar gene expression.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Article
  16. Mild cognitive impairment in Huntington's disease: challenges and outlooks.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 14 institutions in 8 countries.

Peter McColganHuntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square, London, United Kingdom.
Sarah GregoryHuntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square, London, United Kingdom.
Kiran K SeunarineDevelopmental Imaging and Biophysics Section, UCL Institute of Child Health, Queen Square, London, United Kingdom.
Adeel RaziWellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, Queen Square, London, United Kingdom; Department of Electronic Engineering, NED University of Engineering and Technology, Karachi, Pakistan.
Marina PapoutsiHuntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square, London, United Kingdom.
Eileanoir JohnsonHuntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square, London, United Kingdom.
Alexandra DurrAPHP Department of Genetics, University Hospital Pitié-Salpêtrière; and ICM (Brain and Spine Institute) INSERM U1127, CNRS UMR7225, Sorbonne Universités - UPMC Paris VI UMR_S1127, Paris, France.
Raymund A C RoosDepartment of Neurology, Leiden University Medical Centre, Leiden, the Netherlands.
Blair R LeavittCentre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
Peter HolmansMRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Rachael I ScahillHuntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square, London, United Kingdom.
Chris A ClarkDevelopmental Imaging and Biophysics Section, UCL Institute of Child Health, Queen Square, London, United Kingdom.
Geraint ReesWellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, Queen Square, London, United Kingdom.
Sarah J TabriziHuntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square, London, United Kingdom; National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom. Electronic address: s.tabrizi@ucl.ac.uk.
Track-On HD Investigators
Huntington's Disease Association · GBUniversity College London · GBSorbonne Université · FRUniversity of British Columbia · CALeiden University Medical Center · NLUniversität Ulm · DEGeorge Huntington Institute · DEMonash University · AUCardiff University · GBCentre National de la Recherche Scientifique · FRNED University of Engineering and Technology · PKUniversity of Iowa · USUniversity of Manchester · GBWellcome Centre for Human Neuroimaging · GB

Funding

Medical Research Council MR/K023268/1Medical Research Council MR/L010305/1Medical Research Council MR/L012936/1Medical Research Council MR/L02053X/1Wellcome Trust 091593/Z/10/ZWellcome Trust 103437/Z/13/ZWellcome Trust 200181/Z/15/Z
6 · The paper itself

Abstract

backgroundThe earliest white matter changes in Huntington's disease are seen before disease onset in the premanifest stage around the striatum, within the corpus callosum, and in posterior white matter tracts. While experimental evidence suggests that these changes may be related to abnormal gene transcription, we lack an understanding of the biological processes driving this regional vulnerability.

methodsHere, we investigate the relationship between regional transcription in the healthy brain, using the Allen Institute for Brain Science transcriptome atlas, and regional white matter connectivity loss at three time points over 24 months in subjects with premanifest Huntington's disease relative to control participants. The baseline cohort included 72 premanifest Huntington's disease participants and 85 healthy control participants.

resultsWe show that loss of corticostriatal, interhemispheric, and intrahemispheric white matter connections at baseline and over 24 months in premanifest Huntington's disease is associated with gene expression profiles enriched for synaptic genes and metabolic genes. Corticostriatal gene expression profiles are predominately associated with motor, parietal, and occipital regions, while interhemispheric expression profiles are associated with frontotemporal regions. We also show that genes with known abnormal transcription in human Huntington's disease and animal models are overrepresented in synaptic gene expression profiles, but not in metabolic gene expression profiles.

conclusionsThese findings suggest a dual mechanism of white matter vulnerability in Huntington's disease, in which abnormal transcription of synaptic genes and metabolic disturbance not related to transcription may drive white matter loss.

Indexed as

Cerebral CortexCorpus StriatumGene ExpressionGene Expression ProfilingHuntington DiseaseNerve NetTranscriptomeWhite MatterCross-Sectional StudiesDiffusion Tensor ImagingFollow-Up StudiesHumansMagnetic Resonance ImagingProdromal SymptomsConnectomeGeneticsHuntington's diseaseImagingTranscriptionWhite matter

Identifiers

PMID29174593
PMCPMC5803509
OpenAlexW2765263555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.